Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02368860
What this trial is testing

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Centre, Singapore 33
Testing effectiveness (Phase 2)Study completedNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Study completedNCT01869725
What this trial is testing

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Who this might be right for
Adult MedulloblastomaChildhood MedulloblastomaNeuroblastoma+2 more
Sue O'Dorisio 68
Testing effectiveness (Phase 2)Study completedNCT00191568
What this trial is testing

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Eli Lilly and Company 45
Not applicableStudy completedNCT01985958
What this trial is testing

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Who this might be right for
Histological or Cytological Diagnosis of Pancreatic Carcinoma
Abramson Cancer Center at Penn Medicine 4
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Not applicableUnknownNCT05997147
What this trial is testing

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Predictive Cancer ModelPancreas Cancer
Tianjin Medical University Cancer Institute and Hospital 1,009
Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Very early researchEnded earlyNCT03519308
What this trial is testing

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 3
Not applicableActive Not RecruitingNCT06255808
What this trial is testing

Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor

Who this might be right for
Breast CancerBreast NeoplasmArtificial Intelligence+2 more
Seoul National University Hospital 200
Early research (Phase 1)UnknownNCT00639925
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 5
Testing effectiveness (Phase 2)Study completedNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Not applicableNot Yet RecruitingNCT07791550
What this trial is testing

Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy

Who this might be right for
Pancreatic NeoplasmsPancreatic CancerDrug-Related Side Effects and Adverse Reactions (MeSH Term)
Tianjin Medical University Cancer Institute and Hospital 96
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT05220046
What this trial is testing

Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers

Who this might be right for
Pancreas CancerBiliary Tract CancerPsychological Distress+1 more
University of Nebraska 18
Testing effectiveness (Phase 2)Ended earlyNCT03848182
What this trial is testing

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Einstein College of Medicine 10
Not applicableUnknownNCT01455610
What this trial is testing

Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

Who this might be right for
Adenocarcinoma of Head of Pancreas
Meng Su Zeng 140
Not applicableActive Not RecruitingNCT03022188
What this trial is testing

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

Who this might be right for
Neuroendocrine Tumors
Société Française d'Endoscopie Digestive 100
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Not applicableStudy completedNCT02517268
What this trial is testing

Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 98
Next Page